Posted in News FDA committee says Pfizer-BioNTech boosters should be targeted, citing lack of data for people under 65. Latest COVID-19 updates September 17, 2021 An FDA committee on Friday approved a third Pfizer dose six months after full vaccination for people 65 and older or at high risk of severe COVID-19. http://rssfeeds.usatoday.com/~/666893694/0/usatoday-newstopstories~FDA-committee-says-PfizerBioNTech-boosters-should-be-targeted-citing-lack-of-data-for-people-under-Latest-COVID-updates/ Share this:TwitterFacebookWhatsAppLinkedInReddit